Back to BALYASNY ASSET MANAGEMENT L.P. BALYASNY ASSET MANAGEMENT L.P.

AGNAGN
7 quarters

Position history for BALYASNY ASSET MANAGEMENT L.P.BALYASNY ASSET MANAGEMENT L.P.'s holdings in ALLERGAN PLC

As of its Q1 2020 13F, Balyasny Asset Management held 521,560 shares of AGN (Allergan), worth $92.4M. Balyasny Asset Management's 13F filings listed AGN from Q4 2018 to Q1 2020, 6 quarterly filings. AGN was 1.1% of Balyasny Asset Management's reported 13F portfolio.

Final Value

$0

Final Shares

0

Total Value Change

-$42.8M

Total Shares Change

-320,370

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2020-Q2
Latest
Exited
0
-100.0%
$00.0%—
0
2020-Q1
Decreased
521,560
-0.4%
$92.4M1.1%—
0
2019-Q4
Increased
523,468
+56.5%
$100.1M0.6%—
60
2019-Q3
Increased
334,589
+316.3%
$56.3M0.4%—
57
2019-Q2
Decreased
80,367
-39.9%
$13.5M0.1%—
0
2019-Q1
Decreased
133,634
-58.3%
$19.6M0.1%—
0
2018-Q4
First report
320,370
-
$42.8M0.3%—
0

Other major holders of AGN: STATE STREET CORP, ADAGE CAPITAL PARTNERS GP, L.L.C., FARALLON CAPITAL MANAGEMENT, L.L.C.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used